Search Results - Simon Alvis

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

    Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus by Sam Illingworth, Ying Di, Maxine Bauzon, Janet Lei-Rossmann, Margaret R. Duffy, Simon Alvis, Brian Champion, André Lieber, Terry Hermiston, Leonard W. Seymour, John Beadle, Kerry D. Fisher

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

    A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE) by Jean‐Pascal Machiels, Ramón Salazar, Sylvie Rottey, Ignacio Durán, Luc Dirix, Karen Geboes, Christine Wilkinson-Blanc, G. Pover, Simon Alvis, Brian Champion, Kerry Fisher, Hilary McElwaine-Johnn, John Beadle, Emiliano Calvo

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

    Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection by Rocio García‐Carbonero, Ramón Salazar, Ignacio Durán, I. Osmán-García, Luis Paz‐Ares, Juan M. Bozada, Valentina Boni, C Blanc, Leonard W. Seymour, John Beadle, Simon Alvis, Brian Champion, Emiliano Calvo, Kerry D. Fisher

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: